ArticlePlants (Basel, Switzerland)2022
Ecophysiological and Growth-Related Traits of Two Geophytes Three Years after the Fire Event in Grassland Steppe.
Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Deliblato Sands is the single largest expanse of sand in Europe. It is the most fire-prone area of Serbia due to the absence of surface water, sandy soils, specific microclimate conditions, and vegetation composition. Post-fire regeneration is a long-term process that includes many aspects of vegetation regrowth and habitat recovery. In the third year following one of the disastrous fires, the growth dynamics of two geophyte species in unburned and burned sites were studied. During the growing season, burned and unburned populations of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.